Procter & Gamble (PG) R&D chief exercises options and sells 15,169 shares

Rhea-AI Filing Summary

Procter & Gamble's Chief Research, Development & Innovation Officer, Aguilar Moses Victor Javier, exercised stock options and sold shares on February 13, 2026. He exercised 15,169 stock options at an exercise price of $91.07 per share, receiving the same number of common shares.

On the same day, he sold 15,169 common shares in an open-market transaction at a weighted average price of $162.2789 per share, within a price range of $162.26 to $162.311. Following these transactions, he held 44,735.4826 common shares directly, plus additional indirect holdings through a retirement plan and an international stock ownership plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aguilar Moses Victor Javier

(Last) (First) (Middle)

ONE PROCTER AND GAMBLE PLAZA

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chf Rsch, Dev & Innov Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		M		15,169	A	$91.07	59,904.4826	D
Common Stock	02/13/2026		S		15,169	D	$162.2789(1)	44,735.4826	D
Common Stock								6,870.2702(2)	I	By Retirement Plan Trustee
Common Stock								428.6033	I	International Stock Ownership Plan (Mexico) Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$91.07	02/13/2026		M			15,169	02/28/2020	02/26/2027	Common Stock	15,169	$0	0	D

Explanation of Responses:

1. Weighted average price of the shares sold. The price range was $162.26 to $162.311. Full information regarding the number of shares sold at each separate price available upon request.

2. Reflects adjustment to PST through December 31, 2025.

	/s/ Wednesday Shipp, attorney-in-fact for Mr. Aguilar Moses	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Procter & Gamble (PG) executive Aguilar Moses do in this Form 4?

Aguilar Moses exercised stock options and sold the resulting shares. He converted 15,169 options into common stock, then sold 15,169 shares in an open-market transaction, leaving him with a direct ownership of 44,735.4826 Procter & Gamble common shares afterward.

How many Procter & Gamble (PG) shares did Aguilar Moses sell and at what price?

He sold 15,169 Procter & Gamble common shares. The weighted average sale price was $162.2789 per share, within a reported trading range of $162.26 to $162.311. These were open-market sales as disclosed in the Form 4 transaction table.

What stock options did Aguilar Moses exercise in this Procter & Gamble (PG) filing?

He exercised a stock option for 15,169 Procter & Gamble shares at an exercise price of $91.07 per share. The option was originally granted on February 28, 2020 and carried an expiration date of February 26, 2027, according to the derivative securities table.

What is Aguilar Moses’s remaining Procter & Gamble (PG) share ownership after these transactions?

After exercising options and selling shares, he held 44,735.4826 Procter & Gamble common shares directly. In addition, he had indirect holdings of 6,870.2702 shares via a retirement plan trustee and 428.6033 shares through an International Stock Ownership Plan (Mexico) trustee.

What role does Aguilar Moses hold at Procter & Gamble (PG) according to this Form 4?

He is identified as an officer of Procter & Gamble, serving as Chief Research, Development & Innovation Officer. The Form 4 box for officer is checked, and his specific title is listed in the relationship section of the filing’s header information.

How is the sale price described in Aguilar Moses’s Procter & Gamble (PG) Form 4?

The filing reports a weighted average sale price of $162.2789 per share. A footnote explains that individual trades occurred between $162.26 and $162.311, and that detailed information on the exact share counts at each price level is available upon request.